万维提示：
1、该刊只有国际刊号。
2、投稿方式：在线投稿。
3、官网网址（微信公众号信息）：
https://www.keaipublishing.com/en/journals/regenesis-repair-rehabilitation/
4、投稿系统：
https://www2.cloud.editorialmanager.com/rerere/default2.aspx
5、官网电话：0755-82552914
6、官网邮箱：edit-office@reg-rep-reh.com
7、出刊日期：季刊，一年出版四期。
8、官方微信公众号：RegRepReh Journal
9、官网信息：2027年12月31日前投稿免收文章处理费
2026年5月6日星期三
Guide for Authors
【官网信息】
Introduction
Types of paper
Research Article (Word limit: 5000-7000)
A complete report on original research and/or clinical studies
A structured abstract is required.
A clear structure is required, which should contain but not confined to the following sections:
Introduction
Material and methods
Results
Discussion
Conclusions
Authors' contribution (For details please visit the link.)
Ethic statement
COI
(acknowledgments/clarification)
Bibliography
Appendices (including multimedia components)
Review Article (Word limit: 7000-9000) A substantial overviews present a complete overview of the state of the art with a comprehensive bibliography, generally, also contains a table of contents. It should cover topics that have seen significant development or progress in recent years, with comprehensive depth and a balanced perspective. Review articles should NOT include unpublished material such as unpublished/original data, submitted manuscripts, or personal communication.
Editorial (Word limit: 1000)
Generally from the (guest) editor of the publication. Can be Foreword, Editorial, Guest Editorial, Preface, etc.
Short Communication (Word limit: 2000)
Short report or announcement of research, usually claiming certain results, which present original and significant material for rapid dissemination. Short Communications are expected to have a higher than average impact on the field rather than report on incremental research.
Guideline/Consensus (Word limit: 10000) (for clinical medicine only)
Guidelines: documents that have been locally or internationally approved and contain general principles that may benefit others in their clinical practice or in writing their own guidelines.
Consensus: evidence-based analyses of issues that integrate findings, ideas and/or conceptual frameworks from a variety of sources in a clear and balanced way.
Meeting Reports, News & Announcements (Word limit: 1500)
Meeting reports Summary of a relevant symposium, workshop, etc. Or, information about a conference (can be a description of the venture, but also a visit report of a scientist who has attended a conference).
Letter to the Editor (Word limit: 2000)
Any items of interest to the wide audience of the publication. The items includes a letter to the editor commenting on previously published articles or a reply to the letter. (The letter or reply needs a "refers-to" DOI or PII number; or argumentative communication, like papers in a discussion, or commentaries, etc.(Subsequent discussion papers need a "refers-to" DOI or PII number).
Perspective (Word limit: 3000)
An article presents a new and unique viewpoint on existing problems, fundamental concepts, or prevalent notions on a specific topic, propose and support a new hypothesis, or discuss the implications of a newly implemented innovation. Perspective pieces may focus on current advances and future directions on a topic and may include original data as well as personal opinion.
As a guideline, Perspective should not normally exceed 3,000 words. Perspectives allow up to 30 references; citations should be selective. Perspectives should include no more than 4 display items (figures, tables and/or boxes).
Submission checklist
You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
E-mail address
Full postal address
All necessary files have been uploaded:
Manuscript:
Include keywords
All figures (include relevant captions)
All tables (including titles, description, footnotes)
Ensure all figure and table citations in the text match the files provided
Indicate clearly if color should be used for any figures in print
Graphical Abstracts / Highlights files (where applicable)
Supplemental files (where applicable)
Further considerations
Manuscript has been 'spell checked' and 'grammar checked'
All references mentioned in the Reference List are cited in the text, and vice versa
Permission has been obtained for use of copyrighted material from other sources (including the Internet)
A competing interests statement is provided, even if the authors have no competing interests to declare
Journal policies detailed in this guide have been reviewed
Referee suggestions and contact details provided, based on journal requirements
For further information, visit our Support Center.
Before you begin
Ethics in publishing
Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.
Submissions to KeAi journals are automatically screened using iThenticate's CrossCheck within the editorial system to detect plagiarism issues including instances of overlapping and similar text in submitted manuscripts. Details can be found here. High similarity papers will be desk rejected.
Ethics approval and consent to participate
Manuscripts reporting studies involving human participants, human data or human tissue must:
include a statement on ethics approval and consent (even where the need for approval was waived)
include the name of the ethics committee that approved the study and the committee's reference number if appropriate
All materials must adhere to high ethical and animal welfare standards. Any use of animals must be based on ethological knowledge and respect for species-specific requirements for health and well-being. A statement indicating that the protocol and procedures employed were ethically reviewed and approved, and the name of the body giving approval, must be included in the Methods section of the manuscript.
Consent for publication
If your research or manuscript contains any individual person's data in any form (including any individual details, images or videos), consent for publication must be obtained from that person, or in the case of children, their parent or legal guardian. All presentations of case reports must have consent for publication.
Studies in humans and animals
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed. All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.
Declaration of interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors should complete the declaration of competing interest statement using this template and upload to the submission system at the Attach/Upload Files step. Note: Please do not convert the .docx template to another file type. Author signatures are not required. If there are no interests to declare, please choose the first option in the template. This statement will be published within the article if accepted. More information.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint, see 'Multiple, redundant or concurrent publication' section of our ethics policy for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article automatically screened by the originality detection service CrossCheck.
Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's WebShop.
Preprints
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Authorship Statement
For transparency, we encourage authors to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing – original draft; Writing – review & editing. Authorship statements should be formatted with the names of authors first and CRediT role(s) following.
Sample CRediT author statement
Zhang San: Conceptualization, Methodology, Software Priya Singh: Data curation, Writing- Original draft preparation. Wang Wu: Visualization, Investigation. Jan Jansen: Supervision. Ajay Kumar: Software, Validation. Sun Qi: Writing- Reviewing and Editing.
More information can be viewed here.
Changes to authorship
This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:
Before the accepted manuscript is published in an online issue: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.
After the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.
Clinical trial results
In line with the position of the International Committee of Medical Journal Editors, the journal will not consider results posted in the same clinical trials registry in which primary registration resides to be prior publication if the results posted are presented in the form of a brief structured (less than 500 words) abstract or table. However, divulging results in other circumstances (e.g., investors' meetings) is discouraged and may jeopardise consideration of the manuscript. Authors should fully disclose all posting in registries of results of the same or closely related work.
Observational Study Reporting Guidelines
Observational Study Reporting Guidelines
In order to improve the quality and transparency of health research, it is recommended that all studies adhere to specific guidelines prior to submission. For more information, please visit: https://www.equator-network.org/reporting-guidelines/
Reporting clinical trials
Randomized controlled trials should be presented according to the CONSORT guidelines. At manuscript submission, authors must provide the CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal and completion, and a detailed description of the randomization procedure. The CONSORT checklist is available online.
Registration of clinical trials
Registration in a public trials registry is a condition for publication of clinical trials in this journal in accordance with International Committee of Medical Journal Editors recommendations. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article. A clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, surgical procedures, devices, behavioural treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration.
Copyright
This journal is a peer-reviewed, fully open access journal owned by The First Affiliated Hospital of Shenzhen University, who retains copyright of the overall compiled journal and the compiled issues. For the single article, Authors will retain copyright alongside scholarly usage rights, and KeAi Communications Co., Ltd. and The First Affiliated Hospital of Shenzhen University will be granted non-exclusive publishing and distribution rights.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated. Please see https://www.elsevier.com/open-access/agreements.
Open Access
Every peer-reviewed research article appearing in this journal will be published open access. This means that the article is universally and freely accessible via the internet in perpetuity, in an easily readable format immediately after publication. The open access publication fee for this journal is USD 1500, plus taxes. All APCs for articles submitted to the journal before the 31-12-2027 will be fully waived.
A CC user license manages the reuse of the article. All articles will be published under one of the following licenses upon author choice, for more details please visit link (https://www.keaipublishing.com/en/journals/regenesis-repair-rehabilitation/open-access-journal/).
Declaration of generative AI in scientific writing
Authors are encouraged to declare the use of generative AI in scientific writing upon submission of the paper. The following guidance refers only to the writing process, and not to the use of AI tools to analyse and draw insights from data as part of the research process:
Generative AI and AI-assisted technologies should only be used in the writing process to improve the readability and language of the manuscript.
The technology must be applied with human oversight and control and authors should carefully review and edit the result, as AI can generate authoritative-sounding output that can be incorrect, incomplete or biased. Authors are ultimately responsible and accountable for the contents of the work.
Authors must not list or cite AI and AI-assisted technologies as an author or co-author on the manuscript since authorship implies responsibilities and tasks that can only be attributed to and performed by humans.
The use of generative AI and AI-assisted technologies in scientific writing can be declared by adding a statement at the end of the manuscript when the paper is first submitted. The statement will appear in the published work and should be placed in a new section before the references list. An example:
Title of new section: Declaration of generative AI and AI-assisted technologies in the writing process.
Statement: During the preparation of this work the author(s) used [NAME TOOL / SERVICE] in order to [REASON]. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the published article.
The declaration does not apply to the use of basic tools, such as tools used to check grammar, spelling and references. If you have nothing to disclose, you do not need to add a statement.
We advise you to read our policy for authors on the use of generative AI and AI-assisted technologies for Elsevier.
Please note: to protect authors’ rights and the confidentiality of their research, this journal does not currently allow the use of Generative AI or AI-assisted technologies such as ChatGPT or similar services by reviewers or editors in the peer review and manuscript evaluation process. We are actively evaluating compliant AI tools and may revise this policy in the future.
Elsevier Researcher Academy
Researcher Academy is a free e-learning platform designed to support early and mid-career researchers throughout their research journey. The "Learn" environment at Researcher Academy offers several interactive modules, webinars, downloadable guides and resources to guide you through the process of writing for research and going through peer review. Feel free to use these free resources to improve your submission and navigate the publication process with ease.
Submission
Submission to this journal proceeds totally online. Use the following guidelines to prepare your article. Via the homepage of this journal (https://www.keaipublishing.com/en/journals/regenesis-repair-rehabilitation/) you will be guided stepwise through the creation and uploading of the various files. The system automatically converts source files to a single Adobe Acrobat PDF version of the article, which is used in the peer-review process. Please note that even though manuscript source files are converted to PDF at submission for the review process, these source files are needed for further processing after acceptance. All correspondence, including notification of the Editor's decision and requests for revision, takes place by e-mail and via the author's homepage, removing the need for a hard-copy paper trail. If you are unable to provide an electronic version, please contact the editorial office prior to submission:
Email: edit-office@reg-rep-reh.com
Tel: +86-755-82552914
ORCiD ID: Our journal supports the use of ORCiD ID. Authors are encouraged to provide ORCiD ID at submission. Authors are encouraged to provide ORCiD ID at submission.
......
更多详见：
https://www.keaipublishing.com/en/journals/regenesis-repair-rehabilitation/guide-for-authors/#gfa-instruction-22
